Insider Buy/Sell Details for the Healthcare Sector — April 2026
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (530)
Nuvalent, Inc. (NUVL)
Porter James Richard — Director
Shares
12,425
Price
$103.78
Total Value
$1.29M
Shares Held After
331,100
% of Holdings
3.6%
Nuvalent, Inc. (NUVL)
Porter James Richard — Director
Shares
11,354
Price
$103.21
Total Value
$1.17M
Shares Held After
343,525
% of Holdings
3.2%
CASTLE BIOSCIENCES INC (CSTL)
MAETZOLD DEREK J — Director
Shares
278
Price
$25.03
Total Value
$6.96K
Shares Held After
2,780
% of Holdings
9.1%
CASTLE BIOSCIENCES INC (CSTL)
MAETZOLD DEREK J — Director
Shares
278
Price
$25.03
Total Value
$6.96K
Shares Held After
2,780
% of Holdings
9.1%
CASTLE BIOSCIENCES INC (CSTL)
MAETZOLD DEREK J — Director
Shares
278
Price
$25.03
Total Value
$6.96K
Shares Held After
2,780
% of Holdings
9.1%
CASTLE BIOSCIENCES INC (CSTL)
MAETZOLD DEREK J — Director
Shares
278
Price
$25.03
Total Value
$6.96K
Shares Held After
2,780
% of Holdings
9.1%
CASTLE BIOSCIENCES INC (CSTL)
MAETZOLD DEREK J — Director
Shares
1,153
Price
$25.03
Total Value
$28.86K
Shares Held After
41,520
% of Holdings
2.7%
CASTLE BIOSCIENCES INC (CSTL)
MAETZOLD DEREK J — Director
Shares
1,357
Price
$25.03
Total Value
$33.97K
Shares Held After
48,852
% of Holdings
2.7%
CASTLE BIOSCIENCES INC (CSTL)
MAETZOLD DEREK J — Director
Shares
6,214
Price
$25.03
Total Value
$155.54K
Shares Held After
21,479
% of Holdings
22.4%
Kiniksa Pharmaceuticals International, plc (KNSA)
Quart Barry D — Director
Shares
6,901
Price
$50.00
Total Value
$345.05K
Shares Held After
12,546
% of Holdings
35.5%
SOPHiA GENETICS SA (SOPH)
Verma Abhimanyu — Chief Technology Officer
Shares
2,519
Price
$4.86
Total Value
$12.24K
Shares Held After
205,430
% of Holdings
1.2%
SOPHiA GENETICS SA (SOPH)
Van Well Daan — Chief Legal Officer
Shares
2,705
Price
$4.86
Total Value
$13.14K
Shares Held After
356,069
% of Holdings
0.8%
SOPHiA GENETICS SA (SOPH)
CARDOZA GEORGE — Chief Financial Officer
Shares
2,520
Price
$4.85
Total Value
$12.21K
Shares Held After
295,274
% of Holdings
0.8%
SOPHiA GENETICS SA (SOPH)
Valente Manuela — Chief People Officer
Shares
2,597
Price
$4.85
Total Value
$12.58K
Shares Held After
221,651
% of Holdings
1.2%
SOPHiA GENETICS SA (SOPH)
Muken Ross — President
Shares
2,600
Price
$4.85
Total Value
$12.60K
Shares Held After
700,521
% of Holdings
0.4%
SOPHiA GENETICS SA (SOPH)
Puylaert Kevin — Chief Sales Officer
Shares
30
Price
$4.83
Total Value
$144.90
Shares Held After
148,230
% of Holdings
0.0%
SOPHiA GENETICS SA (SOPH)
Puylaert Kevin — Chief Sales Officer
Shares
46
Price
$4.86
Total Value
$223.56
Shares Held After
148,260
% of Holdings
0.0%
SOPHiA GENETICS SA (SOPH)
Xu Zhenyu — Chief Scientific Officer
Shares
2,700
Price
$4.85
Total Value
$13.10K
Shares Held After
647,352
% of Holdings
0.4%
SOPHiA GENETICS SA (SOPH)
Camblong Jurgi — Director
Shares
2,600
Price
$4.85
Total Value
$12.61K
Shares Held After
3,731,450
% of Holdings
0.1%
SOPHiA GENETICS SA (SOPH)
Puylaert Kevin — Chief Sales Officer
Shares
548
Price
$4.86
Total Value
$2.66K
Shares Held After
148,306
% of Holdings
0.4%
SOPHiA GENETICS SA (SOPH)
Menu Philippe — Chief Medical Officer
Shares
2,700
Price
$4.85
Total Value
$13.10K
Shares Held After
283,852
% of Holdings
0.9%
Ceribell, Inc. (CBLL)
Chao Xingjuan — Director
Shares
23,554
Price
$18.40
Total Value
$433.39K
Shares Held After
850,347
% of Holdings
2.7%
Ceribell, Inc. (CBLL)
Chao Xingjuan — Director
Shares
1,446
Price
$18.40
Total Value
$26.61K
Shares Held After
850,347
% of Holdings
0.2%
Ceribell, Inc. (CBLL)
Chao Xingjuan — Director
Shares
14,000
Price
$18.40
Total Value
$257.60K
Shares Held After
850,347
% of Holdings
1.6%
Travere Therapeutics, Inc. (TVTX)
Baynes Roy D. — Director
Shares
10,000
Price
$33.00
Total Value
$330.00K
Shares Held After
37,500
% of Holdings
21.1%
Guardant Health, Inc. (GH)
Monroe Terilyn J. — Chief People Officer
Shares
3,832
Price
$92.68
Total Value
$355.15K
Shares Held After
20,990
% of Holdings
15.4%
HALOZYME THERAPEUTICS, INC. (HALO)
Torley Helen — Director
Shares
4,100
Price
$64.02
Total Value
$262.46K
Shares Held After
767,780
% of Holdings
0.5%
HALOZYME THERAPEUTICS, INC. (HALO)
Torley Helen — Director
Shares
5,900
Price
$63.14
Total Value
$372.52K
Shares Held After
771,880
% of Holdings
0.8%
Hims & Hers Health, Inc. (HIMS)
Okupe Oluyemi — Chief Financial Officer
Shares
3,975
Price
$19.98
Total Value
$79.41K
Shares Held After
318,789
% of Holdings
1.2%
Vir Biotechnology, Inc. (VIR)
De Backer Marianne — Director
Shares
72,559
Price
$9.16
Total Value
$664.35K
Shares Held After
948,145
% of Holdings
7.1%
Lexeo Therapeutics, Inc. (LXEO)
Townsend Richard Nolan — Director
Shares
55,000
Price
$5.69
Total Value
$313.14K
Shares Held After
340,106
% of Holdings
13.9%
ALNYLAM PHARMACEUTICALS, INC. (ALNY)
McLaughlin Melissa — Chief Human Resources Officer
Shares
199
Price
$333.94
Total Value
$66.45K
Shares Held After
9,443
% of Holdings
2.1%
ALNYLAM PHARMACEUTICALS, INC. (ALNY)
McLaughlin Melissa — Chief Human Resources Officer
Shares
293
Price
$331.89
Total Value
$97.24K
Shares Held After
9,642
% of Holdings
2.9%
ALNYLAM PHARMACEUTICALS, INC. (ALNY)
McLaughlin Melissa — Chief Human Resources Officer
Shares
829
Price
$330.46
Total Value
$273.95K
Shares Held After
9,935
% of Holdings
7.7%
ALNYLAM PHARMACEUTICALS, INC. (ALNY)
McLaughlin Melissa — Chief Human Resources Officer
Shares
909
Price
$329.76
Total Value
$299.75K
Shares Held After
10,764
% of Holdings
7.8%
ALNYLAM PHARMACEUTICALS, INC. (ALNY)
McLaughlin Melissa — Chief Human Resources Officer
Shares
56
Price
$320.14
Total Value
$17.93K
Shares Held After
11,673
% of Holdings
0.5%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
160
Price
$566.00
Total Value
$90.56K
Shares Held After
40,513
% of Holdings
0.4%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
122
Price
$564.22
Total Value
$68.84K
Shares Held After
40,673
% of Holdings
0.3%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
716
Price
$563.38
Total Value
$403.38K
Shares Held After
40,795
% of Holdings
1.7%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
402
Price
$562.54
Total Value
$226.14K
Shares Held After
41,511
% of Holdings
1.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
520
Price
$561.51
Total Value
$291.99K
Shares Held After
41,913
% of Holdings
1.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
558
Price
$560.10
Total Value
$312.54K
Shares Held After
42,433
% of Holdings
1.3%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
922
Price
$559.41
Total Value
$515.78K
Shares Held After
42,991
% of Holdings
2.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,806
Price
$558.31
Total Value
$1.01M
Shares Held After
43,913
% of Holdings
4.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,386
Price
$557.21
Total Value
$772.29K
Shares Held After
45,719
% of Holdings
2.9%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,219
Price
$556.19
Total Value
$678.00K
Shares Held After
47,105
% of Holdings
2.5%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,209
Price
$555.25
Total Value
$671.30K
Shares Held After
48,324
% of Holdings
2.4%
Oscar Health, Inc. (OSCR)
Bertolini Mark T — Director
Shares
1,000,000
Price
$11.92
Total Value
$11.92M
Shares Held After
10,196,876
% of Holdings
9.8%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
400
Price
$553.96
Total Value
$221.58K
Shares Held After
49,533
% of Holdings
0.8%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
80
Price
$552.65
Total Value
$44.21K
Shares Held After
49,933
% of Holdings
0.2%
Showing 101–150 of 530 transactions (page 3 of 11)